Log in to save to my catalogue

Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities

Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6b337041a5eb46fba37c191faecc4642

Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities

About this item

Full title

Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities

Publisher

Switzerland: MDPI AG

Journal title

Pharmaceuticals (Basel, Switzerland), 2022-12, Vol.15 (12), p.1553

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

To address the continued rise of multi-drug-resistant microorganisms, the development of novel drugs with new modes of action is urgently required. While humans biosynthesize the essential isoprenoid precursors isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) via the established mevalonate pathway, pathogenic protozoa and certain...

Alternative Titles

Full title

Over 40 Years of Fosmidomycin Drug Research: A Comprehensive Review and Future Opportunities

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_6b337041a5eb46fba37c191faecc4642

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6b337041a5eb46fba37c191faecc4642

Other Identifiers

ISSN

1424-8247

E-ISSN

1424-8247

DOI

10.3390/ph15121553

How to access this item